SRPT

Sarepta Therapeutics, Inc. News Headlines

$13.9
*  
0.08
0.58%
Get SRPT Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading SRPT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Sarepta Therapeutics Q4 Loss Widens - Quick Facts
2/26/2015 7:27:00 AM - RTT News


Sarepta Therapeutics Q4 14 Earnings Conference Call At 8:00 AM ET
2/26/2015 7:00:00 AM - RTT News


Sarepta To Present At RBC Capital Markets Conference ; Webcast At 11:30 AM ET
2/24/2015 10:30:00 AM - RTT News


Next Week In Biotech: Arena And Vivus Report, Radiesse And Avedro Ad Comms
2/20/2015 9:00:00 AM - Seeking Alpha


Sarepta Therap.to Present At Leerink Conference; Webcast At 10:15 AM ET
2/11/2015 9:17:00 AM - RTT News


Sarepta Therapeutics, Inc. (SRPT): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
1/27/2015 7:00:00 AM - Investopedia


Convert Catalysts Into Profits: Sagient Research's Edward Stopke
1/23/2015 8:51:00 AM - Seeking Alpha


Seeking Alpha's Biotech Weekly: Roche Takes Control, Shire's A Buyer, And More
1/16/2015 4:00:00 PM - Seeking Alpha


Sarepta Therapeutics Will Present At J.P. Morgan Conference; Webcast At 3:00 PM
1/15/2015 2:00:00 PM - RTT News


Sarepta Is Suffering From Overreaction
1/15/2015 9:00:00 AM - Seeking Alpha


Sarepta Starts Dosing in Duchenne Muscular Dystrophy Study - Analyst Blog
1/15/2015 4:30:00 AM - Investopedia


PTC Therapeutics Starts Rolling NDA Filing for Translarna - Analyst Blog
12/24/2014 4:10:00 AM - Investopedia


Doug Loe: Canada Has Earned Its Spot In The Biotech All-Star Team Photo
12/19/2014 10:53:00 AM - Seeking Alpha


Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst Blog
12/18/2014 7:07:00 AM - Investopedia


BIOD To Report Data Next Month, HALO Shines On Deal News, TTPH Gets Ignited
12/17/2014 11:26:00 PM - RTT News


With Mid-2015 NDA Submission, Sarepta Can Rise
12/12/2014 9:35:00 AM - Seeking Alpha


Sarepta Therapeutics To Present At Oppenheimer Conference; Webcast At 11:30 AM
12/10/2014 10:30:00 AM - RTT News


Rolling With Biotech's Regulatory Punches: Chen Lin
11/25/2014 4:36:00 PM - Seeking Alpha


Marina Biotech: A Forgotten And Grossly Undervalued Game Changer
11/25/2014 11:40:00 AM - Seeking Alpha


Marina Biotech: A Forgotten And Grossly Undervalued Game-Changer
11/25/2014 10:30:00 AM - Seeking Alpha


Celldex Therapeutics To Enter Talks With FDA
11/18/2014 10:26:00 AM - Seeking Alpha


Thinking Differently About Ebola Virus Disease: WBB Securities' Steve Brozak
11/13/2014 4:24:00 PM - Seeking Alpha


5 Stocks To Consider When Playing Ebola
10/29/2014 11:31:00 AM - Seeking Alpha


Ebola Hits NYC: Time To Panic
10/27/2014 8:45:00 AM - Seeking Alpha


Detailed Analysis Of Sarepta's Ebola Virus Cocktail: Full Phase I Clinical Trial Analysis For Non-Scientists
10/18/2014 12:47:00 PM - Seeking Alpha